337 related articles for article (PubMed ID: 2125992)
1. Promoting effect of the peroxisome proliferator, clofibrate, but not di(2-ethylhexyl)phthalate, on urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Hagiwara A; Tamano S; Ogiso T; Asakawa E; Fukushima S
Jpn J Cancer Res; 1990 Dec; 81(12):1232-8. PubMed ID: 2125992
[TBL] [Abstract][Full Text] [Related]
2. Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
de Camargo JL; Shirai T; Kato T; Asamoto M; Fukushima S
Jpn J Cancer Res; 1991 Nov; 82(11):1220-5. PubMed ID: 1752781
[TBL] [Abstract][Full Text] [Related]
3. Summation effect of uracil on the two-stage and multistage models of urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Masui T; Shirai T; Takahashi S; Mutai M; Fukushima S
Carcinogenesis; 1988 Nov; 9(11):1981-5. PubMed ID: 3180336
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Kitahori Y; Konishi N; Shimoyama T; Hiasa Y
Jpn J Cancer Res; 1985 Sep; 76(9):818-22. PubMed ID: 3932279
[TBL] [Abstract][Full Text] [Related]
5. Short-term screening of promoters of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.
Miyata Y; Fukushima S; Hirose M; Masui T; Ito N
Jpn J Cancer Res; 1985 Sep; 76(9):828-34. PubMed ID: 3932281
[TBL] [Abstract][Full Text] [Related]
6. Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of gamma-glutamyl transpeptidase-positive foci development in the liver of rats.
Imaida K; Fukushima S; Shirai T; Ohtani M; Nakanishi K; Ito N
Carcinogenesis; 1983; 4(7):895-9. PubMed ID: 6135514
[TBL] [Abstract][Full Text] [Related]
7. Promoting effects of various agents in rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Kurata Y; Asamoto M; Hagiwara A; Masui T; Fukushima S
Cancer Lett; 1986 Aug; 32(2):125-35. PubMed ID: 3756839
[TBL] [Abstract][Full Text] [Related]
8. Promoting effects of unilateral ureteric ligation on two-stage urinary bladder carcinogenesis in rats.
Miyata Y; Fukushima S; Imaida K; Ito N
Cancer Lett; 1984 Jul; 23(3):265-72. PubMed ID: 6744250
[TBL] [Abstract][Full Text] [Related]
9. Uracil-induced calculi and carcinogenesis in the urinary bladder of rats treated simultaneously with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Okumura M; Shirai T; Tamano S; Ito M; Yamada S; Fukushima S
Carcinogenesis; 1991 Jan; 12(1):35-41. PubMed ID: 1988179
[TBL] [Abstract][Full Text] [Related]
10. Strain differences in N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis in rats.
Nakanowatari J; Fukushima S; Imaida K; Ito N; Nagase S
Jpn J Cancer Res; 1988 Apr; 79(4):453-9. PubMed ID: 3133335
[TBL] [Abstract][Full Text] [Related]
11. Lack of synergism in rat urinary tract carcinogenesis between prior uracil treatment and N-butyl-N-(4-hydroxybutyl)-nitrosamine administration.
Okumura M; Shirai T; Asamoto M; Ogiso T; Fukushima S
Cancer Lett; 1991 Jun; 58(1-2):81-5. PubMed ID: 2049787
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemically demonstrated variation in expression of cathepsin E between uracil-induced papillomatosis and N-butyl-N-(4-hydroxybutyl)nitrosamine-induced preneoplastic and neoplastic changes in rat urinary bladder.
Yamamoto S; Yonezawa S; Ichinose M; Miki K; Masui T; Fukushima S; Inoue H; Tatematsu M
Virchows Arch; 1996 Mar; 427(6):589-94. PubMed ID: 8605570
[TBL] [Abstract][Full Text] [Related]
13. Strong promoting activity of phenylethyl isothiocyanate and benzyl isothiocyanate on urinary bladder carcinogenesis in F344 male rats.
Hirose M; Yamaguchi T; Kimoto N; Ogawa K; Futakuchi M; Sano M; Shirai T
Int J Cancer; 1998 Aug; 77(5):773-7. PubMed ID: 9688312
[TBL] [Abstract][Full Text] [Related]
14. Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Shirai T; Tagawa Y; Fukushima S; Imaida K; Ito N
Cancer Res; 1987 Dec; 47(24 Pt 1):6726-30. PubMed ID: 3677102
[TBL] [Abstract][Full Text] [Related]
15. Dose response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Nakanishi K; Hagiwara A; Shibata M; Imaida K; Tatematsu M; Ito N
J Natl Cancer Inst; 1980 Nov; 65(5):1005-10. PubMed ID: 6933236
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of urinary bladder carcinogenesis by combined treatment with benzyl isothiocyanate and N-butyl-N-(4-hydroxybutyl)nitrosamine in rats after initiation.
Okazaki K; Umemura T; Imazawa T; Nishikawa A; Masegi T; Hirose M
Cancer Sci; 2003 Nov; 94(11):948-52. PubMed ID: 14611670
[TBL] [Abstract][Full Text] [Related]
17. Chemopreventive effects of bovine lactoferrin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat bladder carcinogenesis.
Masuda C; Wanibuchi H; Sekine K; Yano Y; Otani S; Kishimoto T; Tsuda H; Fukushima S
Jpn J Cancer Res; 2000 Jun; 91(6):582-8. PubMed ID: 10874209
[TBL] [Abstract][Full Text] [Related]
18. Effects of promoters on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in the rat.
Ito N; Fukushima S; Shirai T; Nakanishi K
Environ Health Perspect; 1983 Apr; 50():61-9. PubMed ID: 6873032
[TBL] [Abstract][Full Text] [Related]
19. Absence of ras oncogene activation in rat urinary bladder carcinomas induced by N-methyl-N-nitrosourea or N-butyl-N-(4-hydroxybutyl)nitrosamine.
Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Smith RA; Cohen SM
Carcinogenesis; 1992 Dec; 13(12):2281-5. PubMed ID: 1473235
[TBL] [Abstract][Full Text] [Related]
20. Promoting effect of sodium o-phenylphenate and o-phenylphenol on two-stage urinary bladder carcinogenesis in rats.
Fukushima S; Kurata Y; Shibata M; Ikawa E; Ito N
Gan; 1983 Oct; 74(5):625-32. PubMed ID: 6642136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
